elranatamab will boost the level or influence of fentanyl transdermal by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep track of. Elranatamab causes cytokine launch syndrome (CRS) that could suppress exercise of CYP enzymes, leading to improved exposure of CYP substrates.In selecting to implement a drugs, the dangers of get